The plant biotechnology company posted revenue of $6.3 million in the period. In the final minutes of trading on Wednesday, the company's shares hit ...
News
- 22nd Century: 3Q Earnings Snapshot
- To Maintain an Edge in the Market, This Automation Company 'Triple Trains' Its Employees
Watch the video to learn more about Deblasio and Clear Automation's approach to employee training. Related: The CEO of This Biotech Company ...
- The 2018 midterms could have a big impact on healthcare issues from Medicaid to the number of ...
... Trump's drug pricing blueprint more challenging, and this would be net positive for the sector," RBC Capital Markets biotech analyst Brian Abrahams ...
- Neurocrine: 3Q Earnings Snapshot
SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported third-quarter net income of $50.8 million, after reporting a loss in the same ...
- Ultragenyx: 3Q Earnings Snapshot
The biotechnology company posted revenue of $11.8 million in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks ...